Formyl peptide receptors as mediators of intestinal mucosal homeostasis
甲酰基肽受体作为肠粘膜稳态调节剂
基本信息
- 批准号:8667429
- 负责人:
- 金额:$ 40.01万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-09-01 至 2016-05-31
- 项目状态:已结题
- 来源:
- 关键词:ActinsAcuteAgonistAnnexinsAnti-Inflammatory AgentsAnti-inflammatoryApoptosisBacteriaBiochemicalBiologicalBiological ProcessChemicalsClinicalComplexCoupledDevelopmentDiseaseDrug or chemical Tissue DistributionEnteralEnvironmentEpithelialEpithelial Cell ProliferationEpithelial CellsEpitheliumEpitopesEventFPR1 geneFamily memberFocal Adhesion Kinase 1GTP-Binding ProteinsGenerationsGrowthGuanine Nucleotide Exchange FactorsGuanosine Triphosphate PhosphohydrolasesHomeostasisImaging TechniquesInfectionInflammationInflammation MediatorsInflammatoryInflammatory Bowel DiseasesInjuryIntestinal MucosaIntestinesIschemiaKnockout MiceLaboratoriesLigandsLipidsMAP Kinase GeneMaintenanceMechanicsMediatingMediator of activation proteinMicrobeModificationMolecularMonoclonal AntibodiesMucositisNADPH OxidaseNatural regenerationOperative Surgical ProceduresOutcomeOxidation-ReductionPathogenesisPathologicPathway interactionsPatientsPattern recognition receptorPeptidesPhagocytesPhysiological ProcessesPlayPost-Translational Protein ProcessingProcessProductionProliferatingPropertyProtein Tyrosine PhosphataseProteinsProteomicsReactive Oxygen SpeciesReceptor ActivationReceptor SignalingRecoveryRegulationResolutionRoleSignal PathwaySignal TransductionSite-Directed MutagenesisSpatial DistributionSurfaceTherapeuticTherapeutic AgentsTissuescell motilityfMet-Leu-Phe receptorformyl peptidegastrointestinal epitheliumin vivointestinal epitheliumintestinal homeostasislipoxin A4migrationmolecular imagingmouse modelnovelprotein complexreceptorresponse to injurysmall moleculewound
项目摘要
DESCRIPTION (provided by applicant): The gastrointestinal epithelium functions as a dynamic barrier that serves as an interface between luminal contents and underlying tissue compartments, and is thus vital in maintaining mucosal homeostasis. Mucosal wounds have been observed following enteric infection, inflammatory bowel disease and ischemic insults. Disruption of the critical epithelial barrier allows access of luminal contents to immunologically privileged compartments thereby contributing to disease pathogenesis. In response to injury, intestinal epithelial cells (IEC) migrate and proliferate to rapidly cover denuded surfaces and re-establish the epithelia barrier. We have recently identified expression of the N-formyl peptide receptors (FPR1 and FPR2) in the intestinal epithelium. Our studies determined that a bacterial derived N-formyl peptide, fMLF and the endogenous Annexin 1 protein, which are agonists for FPR family members, promote intestinal epithelial cell migration and facilitate wound closure. Additionally, it is becoming evident that a healthy optimized intestinal microflora mediates important roles in normal gut homeostasis and recovery from mucosal insults. Recent experimental results in our laboratory revealed that epithelial cells exposed to fMLF and intact bacteria also rapidly initiate cytoplasmic signaling events, Rac and Cdc2 activation, reactive oxygen species (ROS) production, epithelial cell migration and wound closure. Thus, we believe that FPRs represent important novel type of pattern recognition receptors (PRR) in the intestinal epithelium that transmit homeostatic signaling and facilitate epithelial barrier recovery following pathologic insults. Thus, our overall objectives are to define the pathobiologic function of epithelial FPRs and microbiota in regulating intestinal homeostasis, barrier recovery and resolution of inflammation.
描述(申请人提供):胃肠道上皮起着动态屏障的作用,作为管腔内容物和底层组织间隔之间的接口,因此对维持粘膜内环境的稳定至关重要。在肠道感染、炎症性肠病和缺血性损伤后可观察到粘膜损伤。关键的上皮屏障的破坏允许腔内容物进入免疫特异室,从而促进疾病的发病。作为对损伤的反应,肠上皮细胞(IEC)迁移和增殖以快速覆盖裸露表面并重建上皮屏障。我们最近发现N-甲酰肽受体(FPR1和FPR2)在肠上皮细胞中表达。我们的研究确定,细菌衍生的N-甲酰肽FMLF和内源性Annexin 1蛋白是FPR家族成员的激动剂,它们促进肠上皮细胞迁移并促进伤口闭合。此外,越来越明显的是,健康的优化肠道菌群在正常的肠道内稳态和粘膜损伤的恢复中起着重要的作用。我们实验室最近的实验结果表明,暴露于FMLF和完整细菌的上皮细胞也迅速启动细胞质信号转导事件,激活RAC和CDC2,产生活性氧(ROS),上皮细胞迁移和伤口闭合。因此,我们认为FPR是肠上皮细胞中重要的新型模式识别受体(PRR),它传递动态平衡信号并促进病理损伤后上皮屏障的恢复。因此,我们的总体目标是确定上皮FPR和微生物区系在调节肠道内稳态、屏障恢复和消退炎症方面的病理生物学功能。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ASMA NUSRAT其他文献
ASMA NUSRAT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ASMA NUSRAT', 18)}}的其他基金
Polarity proteins and intestinal mucosal responses to inflammation and injury
极性蛋白和肠粘膜对炎症和损伤的反应
- 批准号:
10442201 - 财政年份:2022
- 资助金额:
$ 40.01万 - 项目类别:
Polarity proteins and intestinal mucosal responses to inflammation and injury
极性蛋白和肠粘膜对炎症和损伤的反应
- 批准号:
10598126 - 财政年份:2022
- 资助金额:
$ 40.01万 - 项目类别:
Formyl peptide receptors as mediators of intestinal mucosal homeostasis
甲酰基肽受体作为肠粘膜稳态调节剂
- 批准号:
9181392 - 财政年份:2015
- 资助金额:
$ 40.01万 - 项目类别:
Formyl peptide receptors as mediators of intestinal mucosal homeostasis
甲酰基肽受体作为肠粘膜稳态调节剂
- 批准号:
9010350 - 财政年份:2015
- 资助金额:
$ 40.01万 - 项目类别:
FASEB SRC on Gastrointestinal Tract XV: Epithelia, Microbes, Inflammation and Can
FASEB SRC 关于胃肠道 XV:上皮、微生物、炎症和罐头病
- 批准号:
8525712 - 财政年份:2013
- 资助金额:
$ 40.01万 - 项目类别:
2012 Annual Meeting of the American Society for Investigative Pathology
2012年美国病理研究学会年会
- 批准号:
8317861 - 财政年份:2012
- 资助金额:
$ 40.01万 - 项目类别:
Intestinal Epithelial Tight Junction Structure-Function
肠上皮紧密连接结构-功能
- 批准号:
8538941 - 财政年份:2011
- 资助金额:
$ 40.01万 - 项目类别:
Formyl peptide receptors as mediators of intestinal mucosal homeostasis
甲酰基肽受体作为肠粘膜稳态调节剂
- 批准号:
8066189 - 财政年份:2011
- 资助金额:
$ 40.01万 - 项目类别:
Intestinal Epithelial Tight Junction Structure-Function
肠上皮紧密连接结构-功能
- 批准号:
8325536 - 财政年份:2011
- 资助金额:
$ 40.01万 - 项目类别:
Intestinal Epithelial Tight Junction Structure-Function
肠上皮紧密连接结构-功能
- 批准号:
8720748 - 财政年份:2011
- 资助金额:
$ 40.01万 - 项目类别:
相似海外基金
Elucidation of acute poisoning mechanism due to abuse of CB1 receptor agonist.
阐明滥用 CB1 受体激动剂引起的急性中毒机制。
- 批准号:
21K17323 - 财政年份:2021
- 资助金额:
$ 40.01万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of acute poisoning mechanism due to abuse of CB1 receptor agonist.
阐明滥用 CB1 受体激动剂引起的急性中毒机制。
- 批准号:
19K19485 - 财政年份:2019
- 资助金额:
$ 40.01万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Tissue repair effect in acute myocardial infarction through mobilization of endogenous Muse cells by sphingosine-1-phosphate receptor 2 agonist
1-磷酸鞘氨醇受体2激动剂动员内源性Muse细胞对急性心肌梗死的组织修复作用
- 批准号:
18K15843 - 财政年份:2018
- 资助金额:
$ 40.01万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
EFFECT OF ACUTE E PROSTAGLANDIN AGONIST N BAL EICO
急性 E 型前列腺素激动剂 N BAL EICO 的作用
- 批准号:
6115624 - 财政年份:1998
- 资助金额:
$ 40.01万 - 项目类别:
EFFECT OF ACUTE E PROSTAGLANDIN AGONIST N BAL EICO
急性 E 型前列腺素激动剂 N BAL EICO 的作用
- 批准号:
6219539 - 财政年份:1998
- 资助金额:
$ 40.01万 - 项目类别:
EFFECT OF ACUTE E PROSTAGLANDIN AGONIST N BAL EICO
急性 E 型前列腺素激动剂 N BAL EICO 的作用
- 批准号:
6276858 - 财政年份:1997
- 资助金额:
$ 40.01万 - 项目类别:
ACUTE CHRONIC HORMONAL CHANGES WITH LHRH-AGONIST THERAPY
LHRH 激动剂治疗引起的急性慢性荷尔蒙变化
- 批准号:
6250152 - 财政年份:1997
- 资助金额:
$ 40.01万 - 项目类别:
ACUTE CHRONIC HORMONAL CHANGES WITH LHRH-AGONIST THERAPY
LHRH 激动剂治疗引起的急性慢性荷尔蒙变化
- 批准号:
6279945 - 财政年份:1997
- 资助金额:
$ 40.01万 - 项目类别:
EFFECT OF ACUTE E PROSTAGLANDIN AGONIST N BAL EICO
急性 E 型前列腺素激动剂 N BAL EICO 的作用
- 批准号:
6246787 - 财政年份:1997
- 资助金额:
$ 40.01万 - 项目类别:
PSYCHOPHARMACOLOGY OF DA AGONIST CNS EFFECTS: ACUTE AND CHRONIC STUDIES
DA 激动剂中枢神经系统影响的精神药理学:急性和慢性研究
- 批准号:
3891471 - 财政年份:
- 资助金额:
$ 40.01万 - 项目类别:














{{item.name}}会员




